Skip to content

A prospective study for comparison of three different laparoscopic hysterectomy surgeries in the treatment of uterine adenomyosis: how's the impact of pelvic floor function

A prospective study for comparison of three different laparoscopic hysterectomy surgeries in the treatment of uterine adenomyosis: how's the impact of pelvic floor function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008761
Enrollment
Unknown
Registered
2016-07-01
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

group A :Laparoscopic Triangle Hysterectomy
group B:Laparoscopic Total Hysterectomy
group C :Laparoscopic Subtotal Hysterectomy

Sponsors

Liuzhou Maternal and Child Health-Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30 to 50 years old (median age 40 years old), no fertility requirements and lower abdominal surgery history; 2. uterine adenomyosis; 3. the cervical thin layer base fluid cytology eliminate cervical lesions; 4. irregular vaginal bleeding, endometrial pathologic examination for benign lesions; 5. No low estrogen symptoms such as hot flashes, sweating.1 year is not taking hormone drugs, eliminates endocrine and metabolic diseases; 6. and ultrasound examination of department of gynaecology to exclude ovarian lesions; 7. no urinary system disease, no history of urinary tract surgery and trauma, urine routine preoperative and postoperative all normal; 8. Today no vaginal wall surfaces, uterine prolapse and urinary bladder bulging history; 9. Pet-name ruby normal kidney function, kidney B ultrasonic examination without exception.

Exclusion criteria

Exclusion criteria: 1. found that the cervical malignant lesions; 2. highly suspected irregular vaginal study abroad is caused by malignant lesions; Other body; 3. with severe diseases (such as unstable blood sugar level of diabetes, heart disease, and other body parts of a malignant tumor, etc.); 4. with severe endometriosis, pelvic adhesion; 5. postmenopausal population; 6. Extensive pelvic endometriosis or; 7. has a history of primary dysmenorrhea.

Design outcomes

Primary

MeasureTime frame
Pelvic muscle strength assessment;SUI;Female sexual life quality evaluation;Psychological assessment;

Countries

China

Contacts

Public ContactZhong Lin

Liuzhou Maternal and Child Health-Care Hospital

554763560@qq.com+86 13978852399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026